Annexes to the interim recommendations for use of the Bharat Biotech BBV152 COVAXIN® vaccine against COVID-19
Grading of evidence – Evidence to recommendations tables
15 March 2022
| COVID-19: Vaccines
Overview
These are the annexes to WHO interim recommendations for the use of the Bharat Biotech BBV152 COVAXIN® vaccine against COVID-19. Annexes 1–6 contain tables that summarize the grading of recommendations, assessment, development and evaluations (GRADE). Annexes 7–9 contain the SAGE evidence to recommendation framework tables (ETR tables).
GRADE and ETR tables are updated as recommendations are updated.
This document has been updated: version 15 March 2022.
WHO Team
Agenda, Policy & Strategy (APS),
Immunization, Vaccines and Biologicals (IVB),
Strategic Advisory Group of Experts on Immunization,
WHO Headquarters (HQ)
Number of pages
25
Reference numbers
WHO Reference Number: WHO/2019-nCoV/vaccines/SAGE_recommendation/BBV152/annexes/2021.1
Copyright
